193 related articles for article (PubMed ID: 1333850)
61. [Role of cytokine signaling pathways of the transforming growth factor-beta (TGF-beta) family in the regulation of hematopoiesis].
Fuchs O
Cas Lek Cesk; 2002 Sep; 141 Suppl():18-22. PubMed ID: 12428417
[TBL] [Abstract][Full Text] [Related]
62. Analysis of interleukin (IL)-1 beta and transforming growth factor (TGF)-beta-induced signal transduction pathways in IL-2 and TGF-beta secretion and proliferation in the thymoma cell line EL4.NOB-1.
Siese A; Jaros PP; Willig A
Scand J Immunol; 1999 Feb; 49(2):139-48. PubMed ID: 10075017
[TBL] [Abstract][Full Text] [Related]
63. In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones.
Takeda S; Gillis S; Palacios R
Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1634-8. PubMed ID: 2784210
[TBL] [Abstract][Full Text] [Related]
64. Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment.
Dormady SP; Bashayan O; Dougherty R; Zhang XM; Basch RS
J Hematother Stem Cell Res; 2001 Feb; 10(1):125-40. PubMed ID: 11276366
[TBL] [Abstract][Full Text] [Related]
65. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
66. Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.
Dubois CM; Ruscetti FW; Palaszynski EW; Falk LA; Oppenheim JJ; Keller JR
J Exp Med; 1990 Sep; 172(3):737-44. PubMed ID: 2143773
[TBL] [Abstract][Full Text] [Related]
67. Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.
Snoeck HW; Weekx S; Moulijn A; Lardon F; Lenjou M; Nys G; Van Ranst PC; Van Bockstaele DR; Berneman ZN
J Exp Med; 1996 Feb; 183(2):705-10. PubMed ID: 8627186
[TBL] [Abstract][Full Text] [Related]
68. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets.
Fox FE; Capocasale RJ; Ford HC; Lamb RJ; Moore JS; Nowell PC
Lymphokine Cytokine Res; 1992 Dec; 11(6):299-305. PubMed ID: 1477183
[TBL] [Abstract][Full Text] [Related]
69. A fraction unresponsive to growth inhibition by TGF-beta among the high-proliferative potential progenitor cells in bone marrow of p53-deficient mice.
Sasaki H; Matsuda M; Lu Y; Ikuta K; Matsuyama S; Hirabayashi Y; Mitsui H; Matsumura T; Muramatsu M; Tsukada T; Aizawa S; Inoue T
Leukemia; 1997 Feb; 11(2):239-44. PubMed ID: 9009087
[TBL] [Abstract][Full Text] [Related]
70. Growth inhibitory effects of transforming growth factor-beta 1 in vivo.
Migdalska A; Molineux G; Demuynck H; Evans GS; Ruscetti F; Dexter TM
Growth Factors; 1991; 4(3):239-45. PubMed ID: 1768436
[TBL] [Abstract][Full Text] [Related]
71. Stem cell proliferation inhibitors.
Wright EG; Pragnell IB
Baillieres Clin Haematol; 1992 Jul; 5(3):723-39. PubMed ID: 1457966
[No Abstract] [Full Text] [Related]
72. Human haemopoietic stem cell assays.
Gordon MY
Blood Rev; 1993 Sep; 7(3):190-7. PubMed ID: 7902155
[TBL] [Abstract][Full Text] [Related]
73. Progression of the myeloid differentiation program is dominant to transforming growth factor-beta 1-induced apoptosis in M1 myeloid leukemic cells.
Selvakumaran M; Reed JC; Liebermann D; Hoffman B
Blood; 1994 Aug; 84(4):1036-42. PubMed ID: 8049423
[TBL] [Abstract][Full Text] [Related]
74. Cytokine expression in periodontal health and disease.
Okada H; Murakami S
Crit Rev Oral Biol Med; 1998; 9(3):248-66. PubMed ID: 9715365
[TBL] [Abstract][Full Text] [Related]
75. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells.
Larocca LM; Teofili L; Sica S; Piantelli M; Maggiano N; Leone G; Ranelletti FO
Blood; 1995 Jun; 85(12):3654-61. PubMed ID: 7780149
[TBL] [Abstract][Full Text] [Related]
76. Effect of transforming growth factor beta on the EL4 thymoma variant EL4/6.1: dissociation of inhibition of proliferation from expression of IL-1 and IL-2 receptors.
Stoeck M; Howe RC; Miescher S; von Fliedner V; MacDonald HR
Immunobiology; 1990 Aug; 181(1):13-21. PubMed ID: 2148734
[TBL] [Abstract][Full Text] [Related]
77. Haemopoietic growth factors in acute myeloblastic and lymphoblastic leukaemia.
Löwenberg B; Touw IP
Baillieres Clin Haematol; 1992 Jul; 5(3):599-618. PubMed ID: 1333847
[TBL] [Abstract][Full Text] [Related]
78. TGF-β conditions intestinal T cells to express increased levels of miR-155, associated with down-regulation of IL-2 and itk mRNA.
Das LM; Torres-Castillo MD; Gill T; Levine AD
Mucosal Immunol; 2013 Jan; 6(1):167-76. PubMed ID: 22785227
[TBL] [Abstract][Full Text] [Related]
79. Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma.
Yang ZZ; Grote DM; Ziesmer SC; Xiu B; Yates NR; Secreto FJ; Hodge LS; Witzig TE; Novak AJ; Ansell SM
PLoS One; 2013; 8(3):e59456. PubMed ID: 23555036
[TBL] [Abstract][Full Text] [Related]
80. [Cell line regulation in hematopoiesis].
Testa N
Gematol Transfuziol; 1991 Aug; 36(8):27-8. PubMed ID: 1752406
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
